CVS Health Corp
CVS: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$52.00 | Pcvyywv | Rtvwfjgz |
CVS Earnings: Management Gives Cautious Near-Term Outlook Due to Elevated Medical Utilization
Narrow-moat CVS Health delivered solid third-quarter results and maintained its 2023-24 outlook. Our estimates appear near management's near-term guidance ranges, and at first glance, our $103 fair value estimate remains intact and well above recent share prices.